60/100BNovo-Nordisk A executives and insider trading
Elin Jager reported no open-market purchases or sales over the last twelve months.
Over the last twelve months Novo-Nordisk A/S's insiders sold 0 shares for 0 USD in 0 sales on the open market, and bought 0 shares in 0 purchases.
Insiders over the last twelve months
- Insider sales
- 0
- Shares sold
- —
- Value sold
- —
- Insider purchasesWhat is insider trading? Insider trading here means the legal trades that a company's executives, directors and large owners make in its shares, reported to the SEC on Form 4.
- 0
Insiders buying against sellingWhat is a Rule 10b5-1 trading plan? A Rule 10b5-1 plan lets an insider fix future trades in advance, while holding no inside information, so later trades follow the plan, not a new decision.
Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).
Executives and directors
The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.
| Name | Position | Age | Shares sold (12 months) | Value sold (12 months) | Shares bought (12 months) | Last sale | Shares held after |
|---|---|---|---|---|---|---|---|
| Elin Jager CEO | SVP, Chief of Staff to CEO, Corporate Strategy & Sustainability and Member of Management Board | 40 | — | — | — | — | — |
| Maziar Mike Doustdar CEO | President, Chief Executive Officer & Member of the Management Board | 56 | — | — | — | — | — |
| Martin Holst Lange | EVP of R&D, Chief Scientific Officer and Member of the Management Board | 56 | — | — | — | — | — |
| Frederik Kier | Senior Vice President of Global Obesity Unit | — | — | — | — | — | — |
| Mads Frederik Rasmussen | Senior VP & Head of Clinical Drug Development | — | — | — | — | — | — |
| Emil Kongshøj Larsen | EVP of International Operations & Member of Management Board | 51 | — | — | — | — | — |
| Jamey Millar | Executive Vice President of US Operations & Member of Management Board | 58 | — | — | — | — | — |
| John F. Kuckelman | SVP, Group General Counsel, Global Legal, IP & Security and Member of Management Board | 54 | — | — | — | — | — |
| Michael Novod | Senior VP & Head of Investor Relations | 47 | — | — | — | — | — |
| Robin Evers | Senior Vice President of Medical Affairs, Regulatory and Safety | 56 | — | — | — | — | — |
| Hong Chow | Executive Vice President of Product & Portfolio Strategy and Member of Management Board | 55 | — | — | — | — | — |
| Tania Sabroe | EVP of People, Organisation and Corporate Affairs & Member of Management Board | 49 | — | — | — | — | — |
| Thilde Hummel Bogebjerg | Executive VP of Enterprise IT & Quality and Member of Management Board | 44 | — | — | — | — | — |
| Xia-Ping Zhou | Senior VP & President of China | — | — | — | — | — | — |
| Karsten Munk Knudsen | Executive Vice President, Chief Financial Officer & Member of the Management Board | 55 | — | — | — | — | — |
Every insider transactionWhat is insider trading? Insider trading here means the legal trades that a company's executives, directors and large owners make in its shares, reported to the SEC on Form 4.
Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.
| Date | Name | Transaction | Shares | Price | Value | Shares held after | Filing |
|---|
Common questions about Novo-Nordisk A's executives and insiders
Source: Financial Modeling PrepVerified against SEC filings